News & HighlightsNews
Rockefeller tops ranking of 1,300 universities in measures of scientific impact and productivity
Released by the European Commission–funded U-Multirank, the survey placed Rockefeller first in categories related to scientific impact and research productivity. The results incorporate data on more than 1,300 institutions in over 90 countries.
Study identifies “night owl” gene variant
Scientists have discovered a common mutation that might explain why some people have trouble going to sleep at night and getting up early. The gene alteration slows the internal biological clock that regulates our sleeping patterns.
For microbes fighting viruses, a fast response means a better defense
Researchers have found that the bacterial immune system targets an invading virus as soon as it enters the cell. This discovery answers a long-standing question about how microbes defend themselves.
New study resolves the structure of the human protein that causes cystic fibrosis
In order to better understand how genetic mutations give rise to cystic fibrosis, researchers need to map the protein responsible for the disorder. The new structure has led to new insights on how this molecular channel functions.
Changes in the vascular system may trigger Alzheimer’s disease
In some people whose cognitive functions are weakened due to Alzheimer’s, the disease can be traced back to changes in the brain’s blood vasculature. Scientists have found that a protein involved in blood clotting and inflammation might offer a potential path to new drugs.
For biologists studying tiny worms, new technologies make big improvements
Two new technologies are helping scientists understand new aspects of organ and nervous system development in C. elegans. One allows them to image worms developing in a natural environment, while the other makes it possible to track single neurons as the worms grow.
Early intervention with new treatment provides durable control of HIV-like virus in monkeys
There are more than 25 drugs to control HIV, yet the virus remains one of the world’s biggest health problems. One of the many challenges with existing therapies is that a dormant version of the virus is always lurking in the background, ready to attack the immune system as soon as treatment is i...
Study tests the “three-hit” theory of autism
Since the first case was documented in the United States in 1938, the causes of autism have remained elusive. Hundreds of genes, as well as environmental exposures, have been implicated in these brain disorders. Sex also seems to have something to do with it: About 80 percent of children diagnose...
A new way to reset gene expression in cancer cells shows promise for leukemia treatment
New findings from Rockefeller University researchers could guide the development of potent combination therapies that deliver more effective and durable treatment of leukemia. In recent work published in Nature, they show it’s possible to deactivate cellular programs involved in tumor growth by d...
Raphael Cohn wins 2017 Weintraub Graduate Student Award
Raphael Cohn, a graduate fellow in Vanessa Ruta’s Laboratory of Neurophysiology and Behavior, is a recipient of this year’s Harold M. Weintraub Graduate Student Award, one of the country’s most prestigious graduate student prizes in the biosciences. The award, given by the Fred Hutchinson Canc...
View
View